Face growing fast, further investment planned
Award winning online research products – eVillage and e-luminate
Social media orientated research growing strongly
1 Gross profit is identified as revenue less cost of sales. Cost of sales includes amounts payable to external suppliers where they are retained to perform part of a project. Cost of sales does not include direct labour costs.
2 Headline measures are defined as being before restructuring costs, acquisition related employee remuneration expenses, share option charges, impairment charges and amortisation.
3 Headline operating margin is calculated by expressing headline operating profit as a percentage of gross profit.
4 Headline earnings per share is defined in note 6.
5 Like-for-like measures exclude discontinued operations, the impact of acquisitions, and the impact of any reclassification of business between reporting segments.
Mark Scott, Chief Executive, commented:
“2011 saw a continuation of the Group’s solid performance and delivery on our strategy of internationalising revenues and growing our pharmaceutical expertise. As a result we are seeing good momentum in the business, demonstrated by our strong cash flow and considerably strengthened balance sheet.
“We are confident that our focus on servicing international clients in the pharmaceutical and other high margin sectors with our innovative digital offerings will continue to drive growth. We are pleased to be able to reflect this confidence by raising the dividend for the fifth consecutive year.”
Year End 2011 Prelim Statement